secwatch.observer — SEC 8-K summary
======================================

Issuer:     Minerva Neurosciences, Inc. (NERV)
CIK:        0001598646
Form:       8-K
Filed at:   2022-12-16T23:59:59+00:00
Accession:  0001193125-22-307381
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Minerva Neurosciences amends CEO Luthringer's employment agreement with enhanced severance terms
--------------------------------------------------------------------------------

- CEO Remy Luthringer to receive 12 months base salary continuation upon termination without cause.
- Pro-rata annual bonus (assumed at 50% of base salary) + accelerated vesting for awards vesting within 6 months.
- Base salary set at $600,096 per year.
- Amendment effective December 13, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1598646/000119312522307381/0001193125-22-307381-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1598646/000119312522307381/d438557d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-307381

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer